RX Profiler: Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer

RX Profiler: Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer

Feature

Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer

Lowell L. Hart, MD 

Approximately 1 in 8 women in the United States will have invasive breast cancer during their lifetime, making breast cancer one of the most common cancer diagnoses in women.1 Breast [ Read More ]

Perspectives

Treatment of Advanced Breast Cancer: A Clinical Pharmacy Perspective

By Val R. Adams, PharmD, FCCP, BCOP, and Allison R. Butts, PharmD, BCOP
Dr Adams is Associate Professor, Pharmacy, Program Director, Hematology/Oncology Pharmacy Residency; Dr Butts is Hematology/Oncology Clinical Pharmacist and Adjunct Assistant Professor, Pharmacy, Comprehensive Breast Care Center, University of Kentucky HealthCare, Lexington

 

At the Markey Cancer Center in Lexington, KY, clinical pharmacists are integral members of the multidisciplinary care team, working in the clinic alongside surgical and medical oncologists, imaging specialists, radiation [ Read More ]

Perspectives

The Importance of Patient Education: A Nurse’s Perspective

Lillie D. Shockney, RN, BS, MAS, ONN-CG, The Johns Hopkins Breast Center; the Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD

 

It is exciting to see that patients with advanced breast cancer are able to receive additional treatment options, because a primary concern of patients with stage IV breast cancer is [ Read More ]

Perspectives

Increasing Focus on Value Related to Cancer Drugs: A Payer Perspective

Matthew P. Mitchell, PharmD, MBA, FAMCP
Director, Pharmacy Services, SelectHealth, Murray, UT

 

Breast cancer is a hot topic among payers. Approximately 12% of women will have invasive breast cancer in their lifetime.1 In 2017 alone, more than 250,000 new cases of invasive [ Read More ]